DANAHER CORP /DE/ (DHR)
Health Care / Life Sciences Tools & Services
$190.28
Below average on several measures. Research carefully.
Neutral
Score based on 5 of 5 models — high confidence
Key Metrics
Estimated Fair Value
Trading above estimated fair value. P/e of 38x implies high growth expectations. eps growth of -5% may not justify the premium.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Neutral
Business quality & competitive moat
Graham
Neutral
Significantly above fair value
Lynch
Neutral
High PEG — growth premium · Slow Grower
Greenblatt
Neutral
Top half (rank 39%)
Similar Stocks
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer